Southwest Airlines (NYSE: LUV) told employees it can avoid layoffs in 2020, but the company will need workers to "sacrifice more" to avoid furloughs next year as the COVID-19 pandemic continues to wreak havoc on the airline industry.
After years of sales decline and a management overhaul last year, Bed, Bath & Beyond (NASDAQ: BBBY) trounced analysts' estimates in the company's second quarter. With prospects finally looking up, is now the time to buy? Let's check it out.
The retail industry has seen massive changes amid the coronavirus pandemic. Before COVID-19, many retailers felt the pressure of the e-commerce onslaught. When the shutdowns caused further pain, many stores could no longer sustain the pressure and went into bankruptcy.
In mid-September, Amazon (NASDAQ: AMZN) Music added podcasts to its content library, firmly placing the tech giant right into the middle of what is quickly becoming a crowded market.
(RTTNews) - Rockwell Automation, Inc. (ROK) and Microsoft Corp. (MSFT) announced a five-year partnership expansion to develop integrated, market-ready solutions. The companies are working to deliver edge-to-cloud-based solutions that connect information between development, oper
The travel and resort businesses have been devastated by COVID-19 in 2020, but you wouldn't notice it by the price of Vail Resorts' (NYSE: MTN) stock. Shares are down a relatively modest 5.5% over the past year, despite a volatile ride. The market doesn't seem to think that, lon
When it comes to saving for retirement, you have choices. You could sock your money away in an IRA, or you could sign up for your employer's 401(k) plan.
It's a bit of an understatement to say that the stock market has been pretty wild this year. The S&P 500 index took a steep drop in March and then rebounded significantly in the following months, and is now up 15% over the past 12 months.
Apple (NASDAQ: AAPL) has been in the spotlight recently. Not only has its stock soared over the past year, but the company also launched new products last month, including new versions of its Apple Watch and iPad. Apple's annual iPhone event is expected to take place this month.
The year 2020 has been a roller coaster for investors. The market crashed after the COVID-19 pandemic took hold in late March, and while it has recovered nicely since then, many stocks remain in the negative (or with modest gains) on the year.
(RTTNews) - TD Bank Group (TD, TD.TO) confirmed Tuesday that upon closing of the acquisition of TD Ameritrade Holding Corp. (AMTD) by Charles Schwab Corp. (SCHW), TD received an approximately 13.5% stake in Schwab, consisting of 9.9% voting common shares and the remainder in non
LONDON/MILAN/MELBOURNE (Reuters Breakingviews) - Corona Capital is a column updated throughout the day by Breakingviews columnists around the world with short, sharp pandemic-related insights.
(RTTNews) - Iron Mountain Inc. (IRM), the storage and information management services company, announced Tuesday the formation of a 300 million+ Euro joint venture with an affiliate of AGC Equity Partners, a London-based global alternative asset manager, to design and develop a
This month, you may have noticed your take-home pay get a little bigger. If you did, that's likely due to President Donald Trump's executive order allowing employers to defer the collection of payroll taxes between Sept. 1 and Dec. 31, 2020.
It wasn't all that long ago that many people saw AstraZeneca (NYSE: AZN) as the leader in the race to develop a coronavirus vaccine. The U.K.-based drugmaker partnered with the University of Oxford and got off to a fast start.
You won't find many stocks that have been more volatile this year than Inovio Pharmaceuticals (NASDAQ: INO). We're talking about a biotech that saw its share price skyrocket more than 300% by early March, only to lose more than half of those gains within a matter of days. Just
Any stock that skyrockets over 4,600% from the beginning of a year through early August is bound to create a lot of buzz in the investment community. Although biotech Novavax (NASDAQ: NVAX) has been around for decades and doesn't yet have a marketed product, its entry into the r
Satsuma Pharmaceuticals, Inc. STSA has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. And for technical investors there is some hope when looking at STSA given that, according to its RSI reading of 13.66, it is